Skip to content
Company

From architecture
to market.

The research is done. The moat is filed. 2026 is for training at scale. 2027 is for going to market. An API for developers. Vertical products for the industries where LLMs cannot be trusted. All at a fraction of the cost of current AI.

Verace AGI
Verace-AGI
Stage
Pre-seed
HQ
Jaipur
Training
2026
To market
2027
The Product Roadmap

Seven products. One architecture.

The same cortical system powers every product we ship. Different packaging, different market, same moat.

Primary Launch
01
Product 01 / 07
2027 H1

VCI API.

The cortical architecture, as a service.

Developer and enterprise access to the full VCI system. Memory, reasoning, confidence tracking, and infinite context available through a single API. For teams building AI products that transformer-based services cannot reliably power.

ModelUsage-based, per-token
02
Product 02 / 07
2027 H2

VCI Enterprise.

On-premise deployment. Fully owned.

Air-gapped, licensed installations for regulated enterprises. Banks, defense, sovereign-cloud customers, and any organization that cannot send data to a third-party API. Full architectural ownership, not a wrapper.

ModelAnnual licensing
03
Product 03 / 07
2027 H2

VCI Legal.

Entire case law in one context.

A legal AI that holds the Constitution, every relevant statute, and case precedent in working memory at once. No chunking. No RAG plumbing. The architecture is built for this. Competes directly with Harvey AI and Lexis+ AI.

ModelPer-seat SaaS, tiered
04
Product 04 / 07
2028

VCI Health.

Clinical reasoning without hallucination.

Clinical documentation and decision support for hospitals and clinics. The system tells you when it is unsure. In regulated medicine, that is the only behaviour that matters. Competes with Hippocratic AI, Nabla, and Suki.

ModelPer-clinician SaaS
Adjacent Markets
05
Product 05 / 07
2028

VCI Finance.

Compliance memory that never forgets.

Risk memos, compliance analysis, and audit support for banks and advisory firms. Every prior case, every prior decision, retained and retrievable.

ModelPer-seat SaaS
06
Product 06 / 07
2028 H2

VCI Edu.

One tutor, years of memory.

Personalized tutor that remembers every student across semesters. Adjusts to what each learner knows, misses, and repeats. No cold starts, no prompt engineering.

ModelPer-student SaaS
07
Product 07 / 07
2029

VCI Embedded.

Small cortical models for devices.

Compact VCI models for IoT, robotics, and wearables. On-device intelligence without cloud dependence. Licensing plus SDK for hardware makers.

ModelLicensing plus SDK
The Plan

₹50 Crore in 2027.
₹1,000 Crore by 2030.

Four quarters. Seven products. Five revenue streams. The plan below is directional. Specific contracts and pipeline are shared in person. These are targets we build around, not guarantees.

The 2027 Plan
Target ₹50 Cr
Q1
Jan – Mar
2027
2Cr
Milestones
  • VCI API public launch
  • First enterprise license closed
  • First custom integration project
Q2
Apr – Jun
2027
6Cr
Milestones
  • VCI Legal private beta
  • Two additional enterprise contracts
  • Developer self-serve scaling on API
Q3
Jul – Sep
2027
15Cr
Milestones
  • VCI Legal public launch
  • Fifty law firms onboarded
  • First multi-seat enterprise expansion
Q4
Oct – Dec
2027
27Cr
Milestones
  • Hundred-plus law firms live
  • Multiple mid-six-figure enterprise deals
  • API revenue compounding
2027 Total50 Cr
The Five-Year Model
2026 — 2030

From zero to ₹1,000 Crore.

2026
Training
pre-revenue · training

Pre-revenue. Architecture training at scale. IP filings completed.

2027
Launch
50Cr

API live. Legal live. First enterprise contracts. First ₹50 Cr.

2028
Scale
200Cr

VCI Health launches. Legal compounds. Enterprise deal count triples.

2029
Expansion
500Cr

Finance and Education verticals ship. International expansion. Multiple six-figure ARR accounts.

2030
Category Leader
1000Cr

VCI Embedded in production. Multimodal ships. ₹1,000 Cr run rate.

What this requires

The 2027 number is not ambitious
because of the revenue.

It is ambitious because it assumes launch on time, architecture validated, and enterprise pipeline converted. Pre-seed capital closes the gap between training complete and API live. That is what the round buys.

Revenue Model

Five revenue streams. One architecture.

Usage-based where volume is high. Subscriptions where workflows are deep. Licenses where data cannot leave the premises.

01
Stream 01 / 05

Usage-based API.

Model

Per-token

Target

Developers, AI product teams

02
Stream 02 / 05

Legal SaaS.

Model

Per-seat monthly

Target

Solo lawyers to global firms

03
Stream 03 / 05

Healthcare SaaS.

Model

Per-clinician monthly

Target

Clinics, hospitals, telemedicine

04
Stream 04 / 05

Enterprise licensing.

Model

Annual, on-prem

Target

Banks, defense, sovereign cloud

05
Stream 05 / 05

Custom integrations.

Model

Project-based

Target

Bespoke VCI deployments

The Moat

Where we compete.

Every serious competitor in our target markets is an LLM wrapper. All work. All ship. All inherit the same failure modes. We compete on the failures transformers cannot fix.

Competitive Landscape
Two flagship verticals

Legal.

01 / 02

Global legal AI on track to ~₹1 lakh Cr by 2030 · Indian legal tech doubling every three years

Entire constitutions, statutes, and precedent held in one context. No chunking. No RAG plumbing.

Competes with
  • ×Harvey AIUS, LLM wrapper, ~₹25,000 Cr valuation
  • ×Lexis+ AIThomson Reuters LLM on proprietary corpus
  • ×CasetextAcquired by Thomson Reuters for ~₹5,400 Cr
  • ×SpotDraftIndian contract AI, ~₹220 Cr Series A
  • ×CasemineIndian legal research, LLM-integrated
Why we win

Every one is built on a transformer. All inherit the same wall: context limits, hallucinations, forgetting. VCI is architecturally incapable of those failure modes.

Healthcare.

02 / 02

Indian healthcare AI heading to ~₹50,000+ Cr by 2030 · Conversational clinic AI barely touched

Clinical reasoning where hallucination is not acceptable. Confidence tracked per response.

Competes with
  • ×Hippocratic AIUS healthcare LLM, ~₹1,000 Cr+ raised
  • ×NablaFrench AI medical scribe, LLM-based
  • ×Suki AIUS voice scribe, transformer-based
  • ×Qure.aiIndian healthcare AI, imaging focus
  • ×Glass AIClinical reasoning LLM
Why we win

Hallucination is the one failure mode regulated medicine cannot absorb. VCI's self-awareness pillar flags its own uncertainty by design. That is the behaviour hospitals actually need.

Adjacent markets03FinanceCompliance, risk memos, audit trails04EducationTutors with year-long student memory05EmbeddedSmall models for IoT, robots, wearables
Back the category
Pre-seed open for the category

A company,
not a demo.

Five revenue streams. Seven products. Two flagship verticals. One architecture. We are raising pre-seed to complete training and ship to market. Let us walk through it.